All Pharma News
IONTAS Collaboration With F-star Enters Oncology Phase 1 Clinical Trial

IONTAS Collaboration With F-star Enters Oncology Phase 1 Clinical Trial
BUSINESSWIRE
29 Jun 2021
Share Share
IONTAS Identifies Novel SARS-CoV-2 Neutralising Antibodies

IONTAS Identifies Novel SARS-CoV-2 Neutralising Antibodies
BUSINESSWIRE
22 Mar 2021
Share Share
IONTAS Identifies Novel SARS-CoV-2 Neutralising Antibodies

IONTAS Identifies Novel SARS-CoV-2 Neutralising Antibodies
BUSINESSWIRE
22 Mar 2021
Share Share
IONTAS and FairJourney Biologics Enter Antibody Discovery Agreement With Quell

IONTAS and FairJourney Biologics Enter Antibody Discovery Agreement With Quell
BUSINESSWIRE
08 Mar 2021
Share Share
Iontas Enters Licensing Agreement with Bristol Myers Squibb

Iontas Enters Licensing Agreement with Bristol Myers Squibb
CONTRACTPHARMA
15 Oct 2020
Share Share
IONTAS Announces a New Collaboration to Identify Novel Immunotherapy Targets

IONTAS Announces a New Collaboration to Identify Novel Immunotherapy Targets
BUSINESSWIRE
07 May 2020
Share Share
Leading Global Antibody Discovery FairJourney Biologics & Iontas SARS-CoV-2

Leading Global Antibody Discovery FairJourney Biologics & Iontas SARS-CoV-2
BUSINESSWIRE
16 Apr 2020
Share Share
IONTAS, Adaptate Enter Antibodies Alliance

IONTAS, Adaptate Enter Antibodies Alliance
PRESS RELEASE
03 Dec 2019
Share Share
IONTAS Announces New Antibody Optimisation Agreement With Teva Pharmaceuticals

IONTAS Announces New Antibody Optimisation Agreement With Teva Pharmaceuticals
BUSINESSWIRE
29 Jul 2019
Share Share
IONTAS Celebrates 5 Years of Antibody Discovery

IONTAS Celebrates 5 Years of Antibody Discovery
BUSINESSWIRE
02 Jul 2018
Share Share